![](/img/cover-not-exists.png)
Response to temozolomide and bevacizumab in a patient with poorly differentiated neuroendocrine carcinoma
Daniel P. Lindholm, Barbro Eriksson, Dan GranbergVolume:
29
Language:
english
Pages:
3
DOI:
10.1007/s12032-010-9789-4
Date:
March, 2012
File:
PDF, 255 KB
english, 2012